Panthera Biopartners Clinches LDC Majority Funding

Deal News | Aug 12, 2025 | Business Growth Fund (BGF)

Panthera Biopartners Clinches LDC Majority Funding

Business Growth Fund (BGF) has successfully exited its investment in Panthera Biopartners, a company known for its leadership in Site Management Organizations (SMO) for clinical trials. This development comes as Panthera secures a majority investment from LDC, marking a significant milestone in its expansion trajectory. Despite the exit, BGF will maintain its strategic interest in the company by reinvesting as a minority shareholder. The influx of capital from LDC is expected to propel Panthera's market positioning and operational capacities within the clinical trials industry.

Sectors

  • Healthcare and Life Sciences
  • Private Equity and Venture Capital

Geography

  • United Kingdom – BGF, LDC, and Panthera Biopartners are all based in the UK, making the region a central hub for this transaction and its implications within the clinical trials market.

Industry

  • Healthcare and Life Sciences – Panthera Biopartners operates within the clinical trials sector, which is a critical aspect of healthcare and life sciences, focusing on the development and testing of new medical treatments.
  • Private Equity and Venture Capital – The article discusses the involvement of private equity firms BGF and LDC, highlighting the role of financial backing and investment strategies in business growth and expansion.

Financials

  • Undisclosed – The financial details of the majority investment from LDC and the minority re-investment by BGF have not been disclosed.

Participants

NameRoleTypeDescription
Business Growth Fund (BGF)Former Majority Investor and Current Minority ShareholderCompanyA UK-based private equity and venture capital firm providing financial support and strategic guidance to growing businesses.
LDCMajority InvestorCompanyLDC is the private equity arm of Lloyds Banking Group, focusing on investing in mid-market businesses to support growth and development.
Panthera BiopartnersTarget CompanyCompanyA leading Site Management Organization specialized in conducting clinical trials efficiently and effectively.